Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Nature Communications|April 21, 2022
RNA polymerase II pausing factor NELF in CD8+ T cells promotes antitumor immunityBogang Wu, Xiaowen Zhang, Huai-Chin Chiang, et al.
Blood|November 28, 2014
Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivoSimrit Parmar, Xiaoying Liu, Amer Najjar, et al.
Molecular Cancer|November 20, 2009
Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regressionAaron E Foster, Fatma V Okur, Ettore Biagi, et al.
Cytotherapy|August 8, 2016
A robust, good manufacturing practice-compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive cell therapyAbdullah Alsuliman, Stanley H Appel, David R Beers, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 18, 2009
Immunotherapy for osteosarcoma: genetic modification of T cells overcomes low levels of tumor antigen expressionNabil Ahmed, Vita S Salsman, Eric Yvon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemiaEttore Biagi, Raphael Rousseau, Eric Yvon, et al.
Molecular Therapy. Methods & Clinical Development|November 16, 2022
Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-βKajal Chaudhry, Ashley Geiger, Ehsan Dowlati, et al.
Blood|May 24, 2003
Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responsesPersis J Amrolia, Giada Muccioli-Casadei, Eric Yvon, et al.
Nature Medicine|November 4, 2008
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaMartin A Pule, Barbara Savoldo, G Doug Myers, et al.
Blood|October 11, 2011
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaChrystal U Louis, Barbara Savoldo, Gianpietro Dotti, et al.
Pageof 4